REAL-WORLD TREATMENT OF PATIENTS WITH OSTEOPOROSIS IN GERMANY- PREVALENCE AND INCIDENCE OF PATIENTS WITH OSTEOPOROSIS AT INCREASED FRACTURE RISK
Author(s)
Groth A1, Toth E2, Gille P3, Joeres L3, Wilke T4
1Ingress-Health HWM GmbH, Wismar, Germany, 2UCB Biopharma SPRL, Brussels, Belgium, 3UCB Pharma GmbH, Monheim, Germany, 4IPAM - Institut für Pharmakoökonomie und Arzneimittellogistik e.V., Wismar, Germany
OBJECTIVES: Osteoporosis represents a major clinical burden worldwide and, with an increasing ageing population, the number of people affected is expected to increase. In Germany, there is a lack of recent osteoporosis epidemiology data. Therefore, we assessed the prevalence/incidence of osteoporosis in a cohort of patients in Germany insured by a sickness fund. METHODS: The analysis was based on claims data from 3.2 million members (~4.4% of the German insured population) of a regional German statutory health insurance fund. Patients with ≥1 inpatient/outpatient osteoporosis diagnoses (ICD10-Codes M80/M81) in 2016 were included. Osteoporosis prevalence/incidence were reported by age/gender and extrapolated to the German population, based on the overall national age/gender demographics. RESULTS: Extrapolating to the German population, the estimated prevalence of osteoporosis in 2016 was 2,997,243 (7%) women and 628,291 (2%) men. Of these, 2,829,538 (94%) were postmenopausal women ≥55 years of age, and 498,073 (79%) were men ≥60 years (using age thresholds defined per the German osteology [DVO] guidelines). In 2016, an increased risk of fracture, defined as per DVO guidelines, was observed in 1,070,597 (36%) women (149,002 [24%] men). 331,970 (11%) women (65,469 [10%] men) had a prevalent vertebral/femoral fracture; 495,775 (17%) women (78,974 [15%] men) had major osteoporotic fractures; 664,953 (22%) women (59,337 [9%] men) had no fracture but received osteoporosis drug therapy; 73,674 (2%) women (24,196 [4%] men) were diagnosed with drug-induced osteoporosis. The incidence of osteoporosis in 2016 was 451,758 (1%) women (136,426 [0.4%] men) and the incidence of vertebral/femoral fracture in this osteoporosis population was 268,407 (57%) women (53,385 [39%] men). CONCLUSIONS: This study confirmed the previously reported 2009 data for the German population in terms of overall prevalence and incidence and female/male distribution. The analysis did not include asymptomatic/unreported fractures, and so may underestimate the actual numbers.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PMS13
Topic
Epidemiology & Public Health
Disease
Musculoskeletal Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now